Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Staphylococcus aureus Bacteria Turns Immune System Against Itself

Published: Thursday, December 05, 2013
Last Updated: Wednesday, December 04, 2013
Bookmark and Share
Scientists use primary human immune defense mechanism to destroy white blood cells.

Around 20 percent of all humans are persistently colonized with Staphylococcus aureus bacteria, a leading cause of skin infections and one of the major sources of hospital-acquired infections, including the antibiotic-resistant strain MRSA.

University of Chicago scientists have recently discovered one of the keys to the immense success of S. aureus-the ability to hijack a primary human immune defense mechanism and use it to destroy white blood cells. The study was published Nov. 15 in Science.

“These bacteria have endowed themselves with weapons to not only anticipate every immune defense, but turn these immune defenses against the host as well,” said Olaf Schneewind, professor and chair of microbiology and senior author of the paper.

Neutrophils, a type of white blood cell that ensnares invaders in neutrophil extracellular traps (NETs), a web-like structure of DNA and proteins, is one of the first lines of defense in the human immune response.

Captured bacteria are then destroyed by amoeba-like white blood cells known as macrophages. However, S. aureus infection sites are often marked by an absence of macrophages, indicating the bacteria somehow defend themselves against the immune system.

To reveal how these bacteria circumvent the human immune response, Schneewind and his team screened a series of S. aureus possessing mutations that shut down genes thought to play a role in infection. They looked to see how these mutated bacteria behaved in live tissue, and identified two strains that were unable to avoid macrophage attack.

When these mutations-to the staphylococcal nuclease (nuc) and adenosine synthase A (adsA) genes respectively-were reversed, infection sites were free of macrophages again.

Looking for a mechanism of action, the researchers grew S. aureus in a laboratory dish alongside neutrophils and macrophages. The white blood cells were healthy in this environment and could clear bacteria. But the addition of a chemical to stimulate NET formation triggered macrophage death.

Realizing that a toxic product was being generated by S. aureus in response to NETs, the team used high performance liquid chromatography and mass spectrometry techniques to isolate the molecule.

They discovered that S. aureus were converting NETs into 2’-deoxyadenosine (dAdo), a molecule that is toxic to macrophages. This effectively turned NETs into a weapon against the immune system.

“Sooner or later almost every human gets some form of S. aureus infection. Our work describes for the first time the mechanism that these bacteria use to exclude macrophages from infected sites,” Schneewind said. “Coupled with previously known mechanisms that suppress the adaptive immune response, the success of these organisms is almost guaranteed.”

S. aureus bacteria are found on the skin or in the respiratory tracts of colonized humans and commonly cause skin infections in the form of abscesses or boils. Normally not dangerous, severe issues arise when the bacteria enter the bloodstream, where they can cause diseases such as sepsis and meningitis. Antibiotic-resistant strains, such as methicillin-resistant S. aureus (MRSA), are difficult to treat and have plagued healthcare systems around the world.

Schneewind and his team hope to leverage their findings toward therapies against S. aureus infections. But both genes and the dAdo molecule are closely related to important human physiological mechanisms, and Schneewind believes targeting these in bacteria, without harming human function, could be difficult.

“In theory you could build inhibitors of these bacterial enzymes or remove them,” Schneewind said. “But these are untested waters and the pursuit of such a goal requires a lot more study.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Microbiome Center to Merge Expertise of UChicago, MBL and Argonne
Researchers to study world of microbes across environments.
Wednesday, May 18, 2016
AbbVie, University of Chicago Collaborate
The University of Chicago and AbbVie have entered into a five-year collaboration agreement designed to improve the pace of discovery and advance medical research in oncology at both organizations.
Thursday, April 21, 2016
New Code for Control of Gene Expression
A new cellular signal discovered by a team of scientists at the University of Chicago and Tel Aviv University provides a promising new lever in the control of gene expression.
Thursday, February 18, 2016
Bacterial Circadian Clocks Set by Metabolism, Not Light
New study finds that metabolism is the primary driver of the circadian rhythm.
Monday, December 14, 2015
New Nanomanufacturing Technique Advances Imaging, Biosensing Technology
Researchers invent a novel way to build nanolenses in large arrays using a combination of chemical and lithographic techniques.
Thursday, December 10, 2015
Enormous Genetic Variation May Shield Tumors from Treatment
Debate over Darwinian selection vs. random mutations emerges at the tumor level.
Wednesday, November 11, 2015
Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
Manipulating microbes maximizes tumor immunity in mice.
Monday, November 09, 2015
Protein Aggregation After Heat Shock Is An Organized, Reversible Response
New study finds protein aggregation after heat exposure is a reversible cellular process, not unrecoverable damage from misfolding.
Friday, September 11, 2015
New Form of DNA Modification May Carry Inheritable Information
Scientists have described the surprising discovery and function of a new DNA modification in insects, worms and algae.
Friday, May 08, 2015
Shape-Shifting Molecule Tricks Viruses Into Mutating Themselves To Death
Study uses two-dimensional infrared spectroscopy to help distinguish between normal and shape-shifted structures.
Thursday, April 16, 2015
Drug-Development Grants Focus On Sleep Apnea, Asthma Research
NIH grants awarded to two University of Chicago research teams will help to develop novel treatments for sleep apnea and asthma.
Tuesday, January 27, 2015
Gut Bacteria that Protect Against Food Allergies Identified
Common gut bacteria prevent sensitization to allergens in a mouse model for peanut allergy, paving the way for probiotic therapies to treat food allergies.
Wednesday, August 27, 2014
Researchers Identify ‘Fat Gene’ Associated with Obesity
Mutations within the gene FTO have been implicated as the strongest genetic determinant of obesity risk in humans, but the mechanism behind this link remained unknown.
Monday, March 17, 2014
Autism and Intellectual Disability Incidence Linked with Environmental Factors
Although autism and intellectual disability have genetic components, environmental causes are thought to play a role.
Monday, March 17, 2014
Staphylococcus Aureus Bacteria Turns Immune System Against Itself
Around 20 percent of all humans are persistently colonized with Staphylococcus aureus bacteria, including the antibiotic-resistant strain MRSA.
Friday, December 13, 2013
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
A Peachy Defense System for Seeds
ETH chemists are developing a new coating method to protect seeds from being eaten by insects. In doing so, they have drawn inspiration from the humble peach and a few of its peers.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!